{
  "pathway": "Pharmacy First - Acute Sinusitis (≥12 years)",
  "metadata": {
    "version": "1.0",
    "lastUpdated": "2025-02-15",
    "sources": [
      "https://clinicalpathways.uk/pharmacy/acute-sinusitis/",
      "https://cks.nice.org.uk/topics/sinusitis-acute/",
      "https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN01010-6a.-Acute-sinusitis-fluticasone-patient-group-direction-Pharmacy-First.pdf",
      "https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN01010-6b.-Acute-sinusitis-phenoxymethylpenicillin-patient-group-direction-Pharmacy-First.pdf",
      "https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN01010-6c.-Acute-sinusitis-clarithromycin-patient-group-direction-Pharmacy-First.pdf",
      "https://www.england.nhs.uk/wp-content/uploads/2023/11/PRN01010-6d.-Acute-sinusitis-erythromycin-patient-group-direction-Pharmacy-First.pdf"
    ],
    "niceGuideline": "NICE CKS Acute sinusitis"
  },
  "notes": [
    "Acute sinusitis usually viral and self-limiting; antibiotics rarely shorten illness. Provide TARGET RTI self-care leaflets and emphasise analgesia, hydration, and nasal saline rinses.",
    "Exclude pregnant individuals under 16 years, immunosuppressed patients, chronic sinusitis (>12 weeks) and those requiring urgent ENT review (orbital involvement, severe swelling, CNS symptoms).",
    "Use shared decision-making to balance high-dose intranasal corticosteroid vs antibiotic supply; record severity, duration (>10 days), and patient preference.",
    "If providing fluticasone, counsel on correct nasal spray technique, potential epistaxis, and off-label status for sinusitis (supported by NICE).",
    "Safety-net for red flags: periorbital cellulitis, visual disturbance, severe frontal headache, drowsiness, or neurological signs—refer immediately."
  ],
  "decisionTree": {
    "id": "risk_screen",
    "type": "decision",
    "title": "Consider the risk of deterioration or serious illness",
    "question": "Does the patient have complications or high-risk features?",
    "details": {
      "complications": [
        "Periorbital cellulitis or swelling",
        "Severe facial pain with neurological symptoms",
        "Signs of sepsis or meningitis"
      ],
      "escalation": [
        "Ophthalmic involvement, cranial nerve palsy, altered mental status"
      ]
    },
    "yes": {
      "id": "urgent_referral",
      "type": "action",
      "title": "Onward referral",
      "actions": [
        "Arrange same-day GP/ENT/A&E assessment.",
        "Consider NEWS2 prior to calling emergency services.",
        "Do not supply under PGD when complications suspected."
      ],
      "safetyNet": true
    },
    "no": {
      "id": "diagnosis_screen",
      "type": "decision",
      "title": "Clinical diagnosis",
      "question": "Diagnose acute sinusitis based on one or more of: nasal blockage/congestion OR nasal discharge/postnasal drip PLUS one of facial pain/pressure, hyposmia, or cough (children).",
      "yes": {
        "id": "duration_check",
        "type": "decision",
        "title": "Symptom duration",
        "question": "Has the patient had symptoms for ≤10 days?",
        "yes": {
          "id": "self_care_initial",
          "type": "action",
          "title": "Supportive care",
          "actions": [
            "Reassure that sinusitis usually lasts 2–3 weeks and resolves without antibiotics.",
            "Offer analgesics, nasal saline rinses, steam inhalation, hydration, and rest.",
            "Advise to revisit if symptoms worsen or persist beyond 10 days."
          ],
          "safetyNet": true
        },
        "no": {
          "id": "no_improvement",
          "type": "decision",
          "title": "Symptoms >10 days without improvement",
          "question": "Do symptoms show little improvement after 10 days?",
          "no": {
            "id": "continue_selfcare",
            "type": "action",
            "title": "Self-care and pain relief",
            "actions": [
              "Continue supportive management and reassess if deterioration occurs.",
              "Encourage adherence to nasal hygiene and analgesics."
            ],
            "safetyNet": true
          },
          "yes": {
            "id": "gateway_features",
            "type": "decision",
            "title": "Gateway point",
            "question": "Does the patient have ≥2 features suggesting acute bacterial sinusitis?",
            "details": {
              "bacterialFeatures": [
                "Marked deterioration after initial improvement",
                "Fever ≥38 °C",
                "Unremitting purulent nasal discharge",
                "Severe localised unilateral pain (toothache/jaw)"
              ]
            },
            "no": {
              "id": "steroid_option",
              "type": "action",
              "title": "Consider high-dose intranasal corticosteroid",
              "actions": [
                "Offer fluticasone furoate 27.5 micrograms (two actuations twice daily) for 14 days if symptoms moderate/severe and patient prefers non-antibiotic option.",
                "Provide self-care advice and reassess if no improvement in 7 days."
              ],
              "followUp": "Pharmacist review if symptoms persist or worsen.",
              "safetyNet": true
            },
            "yes": {
              "id": "steroid_first_line",
              "type": "decision",
              "title": "First-line management",
              "question": "Shared decision: start high-dose nasal steroid for 14 days (with analgesia). If unsuitable/ineffective consider antibiotics.",
              "details": {
                "steroidGuidance": [
                  "Discuss benefits of intranasal corticosteroid as first option.",
                  "Reserve antibiotics for severe or non-responsive cases."
                ]
              },
              "yes": {
                "id": "steroid_course",
                "type": "treatment",
                "title": "Fluticasone furoate nasal spray",
                "drug": "Fluticasone furoate",
                "durationDays": 14,
                "dose": {
                  "≥12 years": "Two actuations (27.5 mcg each) per nostril twice daily"
                },
                "formulations": [
                  "27.5 micrograms/dose nasal spray"
                ],
                "route": "Intranasal",
                "legalCategory": "POM (PGD)",
                "plus": [
                  "Off-label for sinusitis; supported by NICE.",
                  "Show correct spray technique; avoid directing at nasal septum.",
                  "Warn about possible epistaxis or local irritation."
                ],
                "followUp": "If no improvement within 7 days of treatment start, consider antibiotic assessment.",
                "safetyNet": true
              },
              "no": {
                "id": "antibiotic_branch",
                "type": "decision",
                "title": "Antibiotic consideration",
                "question": "Does the patient meet criteria for antibiotics after steroid failure/intolerance?",
                "yes": {
                  "id": "penicillin_allergy",
                  "type": "decision",
                  "title": "Reported penicillin allergy",
                  "question": "Is there a confirmed penicillin allergy?",
                  "yes": {
                    "id": "pregnancy_check",
                    "type": "decision",
                    "title": "Pregnancy consideration",
                    "question": "Is the patient pregnant?",
                    "yes": {
                      "id": "erythromycin_treatment",
                      "type": "treatment",
                      "title": "Erythromycin (pregnant with penicillin allergy)",
                      "drug": "Erythromycin",
                      "durationDays": 5,
                      "dose": {
                        "Adults": "500 mg four times daily"
                      },
                      "formulations": [
                        "Tablets/capsules 250 mg, 500 mg",
                        "Oral suspension 125 mg/5 mL, 250 mg/5 mL"
                      ],
                      "route": "Oral",
                      "legalCategory": "POM (PGD)",
                      "plus": [
                        "Take with food to minimise GI effects.",
                        "Advise to seek care for jaundice or severe diarrhoea."
                      ],
                      "followUp": "Return if no improvement after 3 days.",
                      "safetyNet": true,
                      "referralIfWorsen": true
                    },
                    "no": {
                      "id": "clarithromycin_or_doxy",
                      "type": "treatment",
                      "title": "Clarithromycin or Doxycycline",
                      "drug": "Clarithromycin OR Doxycycline",
                      "durationDays": 5,
                      "dose": {
                        "Clarithromycin": {
                          "12–17 years": "250 mg twice daily",
                          "Adults": "500 mg twice daily"
                        },
                        "Doxycycline (adults only)": "200 mg stat then 100 mg once daily"
                      },
                      "formulations": [
                        "Clarithromycin tablets 250/500 mg, suspensions",
                        "Doxycycline capsules 100 mg"
                      ],
                      "route": "Oral",
                      "legalCategory": "POM (PGD)",
                      "plus": [
                        "Assess interactions (macrolides with statins/QT drugs; doxycycline contraindicated in pregnancy/under 12 years).",
                        "Advise photosensitivity precautions with doxycycline."
                      ],
                      "followUp": "Review if symptoms worsen or fail to improve after treatment.",
                      "safetyNet": true,
                      "referralIfWorsen": true
                    }
                  },
                  "no": {
                    "id": "phenoxymethylpenicillin_treatment",
                    "type": "treatment",
                    "title": "Phenoxymethylpenicillin (first line antibiotic)",
                    "drug": "Phenoxymethylpenicillin",
                    "durationDays": 5,
                    "dose": {
                      "12–17 years": "500 mg four times daily",
                      "Adults": "500 mg four times daily"
                    },
                    "formulations": [
                      "250 mg tablets",
                      "Oral suspension 250 mg/5 mL"
                    ],
                    "route": "Oral on empty stomach",
                    "legalCategory": "POM (PGD)",
                    "plus": [
                      "Continue analgesia and nasal care during antibiotic course.",
                      "Advise to complete 5-day course and seek review if no improvement."
                    ],
                    "followUp": "Return if symptoms worsen or fail to improve after completion.",
                    "safetyNet": true,
                    "referralIfWorsen": true
                  }
                },
                "no": {
                  "id": "monitor_after_steroid",
                  "type": "action",
                  "title": "Monitor after steroid",
                  "actions": [
                    "Continue steroid course and self-care; antibiotics not indicated yet.",
                    "Review in 3–5 days if symptoms worsen or patient remains very symptomatic."
                  ],
                  "safetyNet": true
                }
              }
            }
          }
        }
      },
      "no": {
        "id": "alternative_diagnosis",
        "type": "action",
        "title": "Acute sinusitis less likely",
        "actions": [
          "Consider allergic rhinitis, migraine, dental pathology, or chronic sinusitis.",
          "Refer or treat according to alternative diagnosis and provide safety-netting."
        ],
        "safetyNet": true
      }
    }
  }
}
